Safety, Pharmacokinetics, and Pharmacodynamics of MTX-101 in Healthy Adults and Patients
Clinical trial NCT06324604 · RECRUITING
Trial details
- NCT number
- NCT06324604
- Sponsor
- Mozart Therapeutics Australia Pty Ltd
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-13
- Primary completion
- 2027-03-31
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.